Biologics Spine Cerapedics’ i-FACTOR P-15 Peptide Enhanced Bone Graft, a Trusted Choice in Bone Graft Solutions, Now Approved for Expanded Indications for Use byJosh SandbergSeptember 24, 2024
Spine Top Stories Innovasis Landmark Study on Spinal Fusion Published in Top Spine Journal byTim AllenAugust 22, 2024
Financial Spine Spinal Fusion Device Market Anticipated to Surpass US$ 9.99 Billion by 2030 Driven by Innovations and Expanding Geriatric Demographics byJosh SandbergFebruary 8, 2024
Regulatory Spine Top Stories Providence Medical Technology Announces FDA Clearance of CAVUX® FFS-LX Lumbar Facet Fixation System for 1- and 2-Level Lumbar Spinal Fusion byJosh SandbergJanuary 12, 2024
Regulatory Spine Top Stories Wenzel Spine Receives FDA Clearance Expanding Clinical Indications for primaLOK SP byJosh SandbergAugust 22, 2023
Spine OssDsign surpasses 200 patients in its prospective spinal fusion registry PROPEL byJosh SandbergAugust 17, 2023
Financial Spine Top Stories Spinal Fusion Devices Market Expected to Grow at 4.6% CAGR, Projected to Reach USD 10.8 Billion by 2032 byJosh SandbergJuly 10, 2023
Regulatory Spine DirectSync Surgical receives Breakthrough Device Designation from FDA for its Patient-Powered Smart Implants byJosh SandbergMay 2, 2023
Neuro Spine SynerFuse™ Announces Solo Spine Surgeon Implants 8th Patient in Integrated Spinal Fusion and DRG Neuromodulation Proof-of-Concept Study byChris StewartJanuary 9, 2023
Biologics Spine Karolinska Development’s portfolio company OssDsign has published a case report from the TOP FUSION study in a scientific journal byJosh SandbergJanuary 4, 2023
